[{"edinetCode":"E00941","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":278.0,"averageTemporaryStaff":67.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11439000.0,"sharesOwendPercent":0.551,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":456.49,"equityRatio":0.648,"cashAndCashEquivalents":2877000000.0,"assets":14320000000.0,"currentAssets":5976000000.0,"fixedAsset":8343000000.0,"tangibleFixedAssets":5813000000.0,"intangibleFixedAssets":202000000.0,"investmentAndOtherAssets":2327000000.0,"liabilities":5035000000.0,"currentLiabilities":2881000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":692000000.0,"fixedLiabilities":2154000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":875000000.0,"netAsset":9284000000.0,"capitalStock":8452000000.0,"capital":3537000000.0,"capitalSurplus":963000000.0,"accumulatedEarnings":4089000000.0,"treasuryStock":-137000000.0,"valuationAndConversionAdjustments":832000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":10967000000.0,"costOfSales":5167000000.0,"grossProfit":5799000000.0,"sgaExpenses":5258000000.0,"salaryAndBenefit":null,"depreciationAndSGA":144000000.0,"RDExpenses":1031000000.0,"operatingIncome":427000000.0,"nonOperatingIncome":42000000.0,"nonOperatingExpenses":26000000.0,"interestExpense":11000000.0,"ordinaryProfit":443000000.0,"extraordinaryGain":null,"extraordinaryLoss":63000000.0,"incomeBeforeTax":379000000.0,"incomeTaxes":138000000.0,"netIncome":240000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":240000000.0,"comprehensiveIncome":303000000.0,"eps":11.84,"dilutedEps":null,"dividendPerShare":null,"per":52.7,"roe":0.026,"cashFlowFromOperatingActivities":1301000000.0,"depreciationAndCashflowFromOperatingActivities":708000000.0,"cashFlowFromInvestingActivities":-227000000.0,"cashFlowFromFinancialActivities":216000000.0,"changesInCashAndCashEquivalents":1291000000.0,"列1":"asr","submitDate":"2017\/6\/29","stockCode":4524,"accountingYear":"第80期(自　平成28年４月１日　至　平成29年３月31日)","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":293.0,"averageTemporaryStaff":61.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2288700.0,"sharesOwendPercent":0.562,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":2409.68,"equityRatio":0.684,"cashAndCashEquivalents":2097000000.0,"assets":14335000000.0,"currentAssets":5473000000.0,"fixedAsset":8861000000.0,"tangibleFixedAssets":5694000000.0,"intangibleFixedAssets":158000000.0,"investmentAndOtherAssets":3008000000.0,"liabilities":4533000000.0,"currentLiabilities":2347000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":347000000.0,"fixedLiabilities":2186000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":757000000.0,"netAsset":9801000000.0,"capitalStock":8692000000.0,"capital":3537000000.0,"capitalSurplus":963000000.0,"accumulatedEarnings":4330000000.0,"treasuryStock":-139000000.0,"valuationAndConversionAdjustments":1108000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":10800000000.0,"costOfSales":5183000000.0,"grossProfit":5616000000.0,"sgaExpenses":5185000000.0,"salaryAndBenefit":null,"depreciationAndSGA":128000000.0,"RDExpenses":1134000000.0,"operatingIncome":545000000.0,"nonOperatingIncome":29000000.0,"nonOperatingExpenses":14000000.0,"interestExpense":11000000.0,"ordinaryProfit":560000000.0,"extraordinaryGain":null,"extraordinaryLoss":31000000.0,"incomeBeforeTax":529000000.0,"incomeTaxes":135000000.0,"netIncome":394000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":394000000.0,"comprehensiveIncome":670000000.0,"eps":96.88,"dilutedEps":null,"dividendPerShare":null,"per":30.2,"roe":0.04,"cashFlowFromOperatingActivities":454000000.0,"depreciationAndCashflowFromOperatingActivities":616000000.0,"cashFlowFromInvestingActivities":-618000000.0,"cashFlowFromFinancialActivities":-616000000.0,"changesInCashAndCashEquivalents":-780000000.0,"列1":"asr","submitDate":"2018\/6\/28","stockCode":4524,"accountingYear":"第81期（自　平成29年４月１日　至　平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":297.0,"averageTemporaryStaff":57.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2292200.0,"sharesOwendPercent":0.563,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":2402.41,"equityRatio":0.692,"cashAndCashEquivalents":2293000000.0,"assets":14121000000.0,"currentAssets":5691000000.0,"fixedAsset":8430000000.0,"tangibleFixedAssets":5358000000.0,"intangibleFixedAssets":271000000.0,"investmentAndOtherAssets":2800000000.0,"liabilities":4350000000.0,"currentLiabilities":2319000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":334000000.0,"fixedLiabilities":2030000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":860000000.0,"netAsset":9771000000.0,"capitalStock":8841000000.0,"capital":3537000000.0,"capitalSurplus":963000000.0,"accumulatedEarnings":4479000000.0,"treasuryStock":-139000000.0,"valuationAndConversionAdjustments":930000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":10090000000.0,"costOfSales":4717000000.0,"grossProfit":5373000000.0,"sgaExpenses":4972000000.0,"salaryAndBenefit":null,"depreciationAndSGA":131000000.0,"RDExpenses":1043000000.0,"operatingIncome":417000000.0,"nonOperatingIncome":45000000.0,"nonOperatingExpenses":13000000.0,"interestExpense":10000000.0,"ordinaryProfit":449000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":449000000.0,"incomeTaxes":97000000.0,"netIncome":351000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":351000000.0,"comprehensiveIncome":173000000.0,"eps":86.48,"dilutedEps":null,"dividendPerShare":null,"per":26.1,"roe":0.036,"cashFlowFromOperatingActivities":751000000.0,"depreciationAndCashflowFromOperatingActivities":602000000.0,"cashFlowFromInvestingActivities":-441000000.0,"cashFlowFromFinancialActivities":-113000000.0,"changesInCashAndCashEquivalents":195000000.0,"列1":"asr","submitDate":"2019\/6\/27","stockCode":4524,"accountingYear":"第82期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.691,"cashAndCashEquivalents":null,"assets":14220000000.0,"currentAssets":5789000000.0,"fixedAsset":8431000000.0,"tangibleFixedAssets":5322000000.0,"intangibleFixedAssets":319000000.0,"investmentAndOtherAssets":2789000000.0,"liabilities":4387000000.0,"currentLiabilities":2402000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":334000000.0,"fixedLiabilities":1985000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":776000000.0,"netAsset":9833000000.0,"capitalStock":8916000000.0,"capital":3537000000.0,"capitalSurplus":963000000.0,"accumulatedEarnings":4554000000.0,"treasuryStock":-139000000.0,"valuationAndConversionAdjustments":916000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2685000000.0,"costOfSales":1224000000.0,"grossProfit":1461000000.0,"sgaExpenses":1144000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":317000000.0,"nonOperatingIncome":8000000.0,"nonOperatingExpenses":5000000.0,"interestExpense":1000000.0,"ordinaryProfit":319000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":319000000.0,"incomeTaxes":91000000.0,"netIncome":227000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":227000000.0,"comprehensiveIncome":213000000.0,"eps":56.02,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4524,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2294800.0,"sharesOwendPercent":0.564,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.715,"cashAndCashEquivalents":2040000000.0,"assets":14054000000.0,"currentAssets":5597000000.0,"fixedAsset":8456000000.0,"tangibleFixedAssets":5243000000.0,"intangibleFixedAssets":324000000.0,"investmentAndOtherAssets":2887000000.0,"liabilities":4009000000.0,"currentLiabilities":2083000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":334000000.0,"fixedLiabilities":1926000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":692000000.0,"netAsset":10044000000.0,"capitalStock":9060000000.0,"capital":3537000000.0,"capitalSurplus":965000000.0,"accumulatedEarnings":4690000000.0,"treasuryStock":-132000000.0,"valuationAndConversionAdjustments":983000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":5166000000.0,"costOfSales":2428000000.0,"grossProfit":2738000000.0,"sgaExpenses":2238000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":423000000.0,"operatingIncome":500000000.0,"nonOperatingIncome":15000000.0,"nonOperatingExpenses":8000000.0,"interestExpense":4000000.0,"ordinaryProfit":507000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":507000000.0,"incomeTaxes":143000000.0,"netIncome":363000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":363000000.0,"comprehensiveIncome":416000000.0,"eps":89.39,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":383000000.0,"depreciationAndCashflowFromOperatingActivities":309000000.0,"cashFlowFromInvestingActivities":-316000000.0,"cashFlowFromFinancialActivities":-319000000.0,"changesInCashAndCashEquivalents":-252000000.0,"列1":"q2r","submitDate":"2019\/11\/12","stockCode":4524,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.725,"cashAndCashEquivalents":null,"assets":14415000000.0,"currentAssets":5594000000.0,"fixedAsset":8820000000.0,"tangibleFixedAssets":5178000000.0,"intangibleFixedAssets":322000000.0,"investmentAndOtherAssets":3319000000.0,"liabilities":3969000000.0,"currentLiabilities":1979000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":334000000.0,"fixedLiabilities":1990000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":609000000.0,"netAsset":10445000000.0,"capitalStock":9159000000.0,"capital":3537000000.0,"capitalSurplus":965000000.0,"accumulatedEarnings":4788000000.0,"treasuryStock":-132000000.0,"valuationAndConversionAdjustments":1286000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":7468000000.0,"costOfSales":3499000000.0,"grossProfit":3968000000.0,"sgaExpenses":3366000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":601000000.0,"nonOperatingIncome":27000000.0,"nonOperatingExpenses":11000000.0,"interestExpense":6000000.0,"ordinaryProfit":617000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":617000000.0,"incomeTaxes":155000000.0,"netIncome":462000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":462000000.0,"comprehensiveIncome":818000000.0,"eps":113.52,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":4524,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":306.0,"averageTemporaryStaff":55.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2296300.0,"sharesOwendPercent":0.564,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":2459.63,"equityRatio":0.696,"cashAndCashEquivalents":2475000000.0,"assets":14387000000.0,"currentAssets":6258000000.0,"fixedAsset":8129000000.0,"tangibleFixedAssets":4903000000.0,"intangibleFixedAssets":317000000.0,"investmentAndOtherAssets":2908000000.0,"liabilities":4374000000.0,"currentLiabilities":2313000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":408000000.0,"fixedLiabilities":2060000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":821000000.0,"netAsset":10013000000.0,"capitalStock":9018000000.0,"capital":3537000000.0,"capitalSurplus":965000000.0,"accumulatedEarnings":4648000000.0,"treasuryStock":-133000000.0,"valuationAndConversionAdjustments":995000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":9774000000.0,"costOfSales":4597000000.0,"grossProfit":5176000000.0,"sgaExpenses":4731000000.0,"salaryAndBenefit":null,"depreciationAndSGA":262000000.0,"RDExpenses":966000000.0,"operatingIncome":453000000.0,"nonOperatingIncome":67000000.0,"nonOperatingExpenses":14000000.0,"interestExpense":10000000.0,"ordinaryProfit":507000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":46000000.0,"incomeBeforeTax":460000000.0,"incomeTaxes":138000000.0,"netIncome":322000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":322000000.0,"comprehensiveIncome":386000000.0,"eps":79.14,"dilutedEps":null,"dividendPerShare":null,"per":24.3,"roe":0.032,"cashFlowFromOperatingActivities":804000000.0,"depreciationAndCashflowFromOperatingActivities":787000000.0,"cashFlowFromInvestingActivities":-505000000.0,"cashFlowFromFinancialActivities":-117000000.0,"changesInCashAndCashEquivalents":182000000.0,"列1":"asr","submitDate":"2020\/6\/26","stockCode":4524,"accountingYear":"第83期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.706,"cashAndCashEquivalents":null,"assets":14282000000.0,"currentAssets":5992000000.0,"fixedAsset":8289000000.0,"tangibleFixedAssets":4842000000.0,"intangibleFixedAssets":372000000.0,"investmentAndOtherAssets":3074000000.0,"liabilities":4192000000.0,"currentLiabilities":2154000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":408000000.0,"fixedLiabilities":2037000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":719000000.0,"netAsset":10089000000.0,"capitalStock":8987000000.0,"capital":3537000000.0,"capitalSurplus":965000000.0,"accumulatedEarnings":4617000000.0,"treasuryStock":-133000000.0,"valuationAndConversionAdjustments":1102000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2351000000.0,"costOfSales":1134000000.0,"grossProfit":1216000000.0,"sgaExpenses":1056000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":160000000.0,"nonOperatingIncome":7000000.0,"nonOperatingExpenses":2000000.0,"interestExpense":2000000.0,"ordinaryProfit":165000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":165000000.0,"incomeTaxes":43000000.0,"netIncome":121000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":121000000.0,"comprehensiveIncome":229000000.0,"eps":29.93,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/7","stockCode":4524,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2299200.0,"sharesOwendPercent":0.564,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.716,"cashAndCashEquivalents":2091000000.0,"assets":14345000000.0,"currentAssets":5985000000.0,"fixedAsset":8360000000.0,"tangibleFixedAssets":4770000000.0,"intangibleFixedAssets":360000000.0,"investmentAndOtherAssets":3228000000.0,"liabilities":4078000000.0,"currentLiabilities":2094000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":408000000.0,"fixedLiabilities":1984000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":617000000.0,"netAsset":10266000000.0,"capitalStock":9058000000.0,"capital":3537000000.0,"capitalSurplus":966000000.0,"accumulatedEarnings":4681000000.0,"treasuryStock":-126000000.0,"valuationAndConversionAdjustments":1207000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":4889000000.0,"costOfSales":2404000000.0,"grossProfit":2485000000.0,"sgaExpenses":2252000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":518000000.0,"operatingIncome":232000000.0,"nonOperatingIncome":13000000.0,"nonOperatingExpenses":5000000.0,"interestExpense":4000000.0,"ordinaryProfit":240000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":null,"incomeBeforeTax":241000000.0,"incomeTaxes":55000000.0,"netIncome":185000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":185000000.0,"comprehensiveIncome":398000000.0,"eps":45.61,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":99000000.0,"depreciationAndCashflowFromOperatingActivities":294000000.0,"cashFlowFromInvestingActivities":-127000000.0,"cashFlowFromFinancialActivities":-356000000.0,"changesInCashAndCashEquivalents":-384000000.0,"列1":"q2r","submitDate":"2020\/11\/10","stockCode":4524,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.73,"cashAndCashEquivalents":null,"assets":14106000000.0,"currentAssets":5726000000.0,"fixedAsset":8380000000.0,"tangibleFixedAssets":4776000000.0,"intangibleFixedAssets":360000000.0,"investmentAndOtherAssets":3243000000.0,"liabilities":3810000000.0,"currentLiabilities":1884000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":491000000.0,"fixedLiabilities":1926000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":532000000.0,"netAsset":10296000000.0,"capitalStock":9078000000.0,"capital":3537000000.0,"capitalSurplus":966000000.0,"accumulatedEarnings":4701000000.0,"treasuryStock":-126000000.0,"valuationAndConversionAdjustments":1217000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":7151000000.0,"costOfSales":3536000000.0,"grossProfit":3615000000.0,"sgaExpenses":3360000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":254000000.0,"nonOperatingIncome":25000000.0,"nonOperatingExpenses":7000000.0,"interestExpense":7000000.0,"ordinaryProfit":272000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":null,"incomeBeforeTax":273000000.0,"incomeTaxes":67000000.0,"netIncome":205000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":205000000.0,"comprehensiveIncome":428000000.0,"eps":50.43,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":4524,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":331.0,"averageTemporaryStaff":52.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2299800.0,"sharesOwendPercent":0.564,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":2521.16,"equityRatio":0.711,"cashAndCashEquivalents":2703000000.0,"assets":14446000000.0,"currentAssets":6111000000.0,"fixedAsset":8335000000.0,"tangibleFixedAssets":4734000000.0,"intangibleFixedAssets":389000000.0,"investmentAndOtherAssets":3211000000.0,"liabilities":4173000000.0,"currentLiabilities":2074000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":492000000.0,"fixedLiabilities":2098000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":749000000.0,"netAsset":10273000000.0,"capitalStock":9079000000.0,"capital":3537000000.0,"capitalSurplus":966000000.0,"accumulatedEarnings":4702000000.0,"treasuryStock":-126000000.0,"valuationAndConversionAdjustments":1193000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":9429000000.0,"costOfSales":4641000000.0,"grossProfit":4788000000.0,"sgaExpenses":4562000000.0,"salaryAndBenefit":null,"depreciationAndSGA":166000000.0,"RDExpenses":1063000000.0,"operatingIncome":223000000.0,"nonOperatingIncome":40000000.0,"nonOperatingExpenses":11000000.0,"interestExpense":9000000.0,"ordinaryProfit":253000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":1000000.0,"incomeBeforeTax":252000000.0,"incomeTaxes":45000000.0,"netIncome":206000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":206000000.0,"comprehensiveIncome":405000000.0,"eps":50.69,"dilutedEps":null,"dividendPerShare":null,"per":39.6,"roe":0.02,"cashFlowFromOperatingActivities":871000000.0,"depreciationAndCashflowFromOperatingActivities":590000000.0,"cashFlowFromInvestingActivities":-502000000.0,"cashFlowFromFinancialActivities":-141000000.0,"changesInCashAndCashEquivalents":227000000.0,"列1":"asr","submitDate":"2021\/6\/29","stockCode":4524,"accountingYear":"第84期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.698,"cashAndCashEquivalents":null,"assets":14578000000.0,"currentAssets":6154000000.0,"fixedAsset":8424000000.0,"tangibleFixedAssets":4925000000.0,"intangibleFixedAssets":385000000.0,"investmentAndOtherAssets":3113000000.0,"liabilities":4398000000.0,"currentLiabilities":2399000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":444000000.0,"fixedLiabilities":1999000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":674000000.0,"netAsset":10179000000.0,"capitalStock":9059000000.0,"capital":3537000000.0,"capitalSurplus":966000000.0,"accumulatedEarnings":4682000000.0,"treasuryStock":-126000000.0,"valuationAndConversionAdjustments":1120000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2435000000.0,"costOfSales":1189000000.0,"grossProfit":1246000000.0,"sgaExpenses":1079000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":166000000.0,"nonOperatingIncome":9000000.0,"nonOperatingExpenses":2000000.0,"interestExpense":2000000.0,"ordinaryProfit":173000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":173000000.0,"incomeTaxes":41000000.0,"netIncome":132000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":132000000.0,"comprehensiveIncome":59000000.0,"eps":32.56,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/10","stockCode":4524,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2282400.0,"sharesOwendPercent":0.559,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.709,"cashAndCashEquivalents":2487000000.0,"assets":14581000000.0,"currentAssets":5911000000.0,"fixedAsset":8669000000.0,"tangibleFixedAssets":4835000000.0,"intangibleFixedAssets":472000000.0,"investmentAndOtherAssets":3361000000.0,"liabilities":4236000000.0,"currentLiabilities":2226000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":396000000.0,"fixedLiabilities":2010000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":599000000.0,"netAsset":10344000000.0,"capitalStock":9049000000.0,"capital":3537000000.0,"capitalSurplus":967000000.0,"accumulatedEarnings":4665000000.0,"treasuryStock":-120000000.0,"valuationAndConversionAdjustments":1294000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":4703000000.0,"costOfSales":2322000000.0,"grossProfit":2380000000.0,"sgaExpenses":2237000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":443000000.0,"operatingIncome":143000000.0,"nonOperatingIncome":17000000.0,"nonOperatingExpenses":4000000.0,"interestExpense":4000000.0,"ordinaryProfit":155000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":155000000.0,"incomeTaxes":40000000.0,"netIncome":115000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":115000000.0,"comprehensiveIncome":216000000.0,"eps":28.29,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":510000000.0,"depreciationAndCashflowFromOperatingActivities":290000000.0,"cashFlowFromInvestingActivities":-328000000.0,"cashFlowFromFinancialActivities":-398000000.0,"changesInCashAndCashEquivalents":-216000000.0,"列1":"q2r","submitDate":"2021\/11\/10","stockCode":4524,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0},{"edinetCode":"E00941","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.728,"cashAndCashEquivalents":null,"assets":14090000000.0,"currentAssets":5866000000.0,"fixedAsset":8224000000.0,"tangibleFixedAssets":4553000000.0,"intangibleFixedAssets":459000000.0,"investmentAndOtherAssets":3211000000.0,"liabilities":3833000000.0,"currentLiabilities":1927000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":340000000.0,"fixedLiabilities":1906000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":531000000.0,"netAsset":10257000000.0,"capitalStock":9069000000.0,"capital":3537000000.0,"capitalSurplus":967000000.0,"accumulatedEarnings":4684000000.0,"treasuryStock":-120000000.0,"valuationAndConversionAdjustments":1188000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":6950000000.0,"costOfSales":3450000000.0,"grossProfit":3500000000.0,"sgaExpenses":3419000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":81000000.0,"nonOperatingIncome":31000000.0,"nonOperatingExpenses":6000000.0,"interestExpense":6000000.0,"ordinaryProfit":105000000.0,"extraordinaryGain":44000000.0,"extraordinaryLoss":null,"incomeBeforeTax":150000000.0,"incomeTaxes":15000000.0,"netIncome":135000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":135000000.0,"comprehensiveIncome":129000000.0,"eps":33.13,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/9","stockCode":4524,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00941","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3537,"settlementDate":"2022\/3\/31","submitterName":"森下仁丹株式会社","submitterNameEnglish":"MORISHITA JINTAN CO.,LTD.","submitterNameKana":"モリシタジンタンカブシキガイシャ","location":"大阪市中央区玉造一丁目２番４０号","industory":"医薬品","corporateNumber":8120000000000.0}]